Monopar Therapeutics Inc banner

Monopar Therapeutics Inc
F:1IY

Watchlist Manager
Monopar Therapeutics Inc Logo
Monopar Therapeutics Inc
F:1IY
Watchlist
Price: 1.85 EUR
Market Cap: €32.6m

Wall St Price Targets

1IY Price Targets Summary
Monopar Therapeutics Inc

Wall Street analysts forecast 1IY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 1IY is 3.74 EUR with a low forecast of 3.28 EUR and a high forecast of 4.44 EUR.

Lowest Forecast
Price Target
3.28 EUR
78% Upside
Average Forecast
Price Target
3.74 EUR
102% Upside
Highest Forecast
Price Target
4.44 EUR
140% Upside
Monopar Therapeutics Inc Competitors:
Price Targets
PGEN
Precigen Inc
124% Upside
LAND
Gladstone Land Corp
28% Upside
SUPN
Supernus Pharmaceuticals Inc
30% Upside
PRQR
ProQR Therapeutics NV
463% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-62%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-62%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 1IY's stock price target?
Price Target
3.74 EUR

According to Wall Street analysts, the average 1-year price target for 1IY is 3.74 EUR with a low forecast of 3.28 EUR and a high forecast of 4.44 EUR.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett